Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

• click to rate

  Posted by Two Blokes May 11 - Filed in Stock - 4 views
  
  Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial.